NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Multiple Sclerosis, Relapsing-Remitting

Countries: Spain

This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participants aged greater than or equal to (\>/=) 18 years
* Participants who have a diagnosis of RRMS as documented in their medical records
* Participants who have been prescribed a DMT for at least 3 months
* Participants who have an expanded disability status scale (EDSS) score of 1-6 points

Exclusion Criteria:

\- Participants with any personal or medical condition that in opinion of the investigator would interfere with or make impossible proper participation in the study

Locations (18)

Sant Joan Despí, Barcelona, Spain
Santander, Cantabria, Spain
Castellon, Castellon, Spain
Lleida, Lerida, Spain
Arganda, Madrid, Spain
Móstoles, Madrid, Spain
Pozuelo de Alarcón, Madrid, Spain
Vigo, Pontevedra, Spain
San Cristóbal de La Laguna, Tenerife, Spain
Barcelona, Spain
Córdoba, Spain
Girona, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Valencia, Spain
Valencia, Spain
Valencia, Spain